This study is an open clinical trial in children aged 6-71 months old. The purpose of this study is to evaluate the safety of EV71 vaccine (Vero cell), inactivated co-administration with other vaccines.The EV71 vaccine was manufactured by Sinovac Biotech Co.A total of 12500 subjects aged 6-71 months old were enrolled.All subjects received one dose of EV71 vaccine and one of other vaccines(such as MMR vaccine,encephalitis vaccine,mumps vaccine,inactivated poliomyelitis vaccine,influenza vaccine and so on ) at the same time.
Age
0–5
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
6 months ≤ Age of enrollment ≤71 months;
Voluntary and self-funded completion of EV71 vaccine combined immunization with one of the other type I or II vaccines;
The subject and/or guardian can understand and voluntarily sign the informed consent form;
Subjects and their legal guardians are able to attend follow-up visits and follow all study procedures (such as cooperating in completing safety observation notes).